Patents by Inventor Hui-Wang Ai

Hui-Wang Ai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7790868
    Abstract: The present invention provides an isolated nucleic acid sequence encoding a non-oligomerizing Clavularia teal fluorescent protein (mTFP) variant having a tyrosine-derived chromophore, as well as fragments and derivatives thereof. Also provided is a method for engineering the nucleic acid sequence, a vector comprising the nucleic acid sequence, a host cell comprising the vector, and use of the vector in a method for expressing the nucleic acid sequence. The present invention further provides an isolated nucleic acid, or mimetic or complement thereof, that hybridizes under stringent conditions to the nucleic acid sequence. Additionally, the present invention provides a non-oligomerizing mTFP variant encoded by the nucleic acid sequence, as well as derivatives, fragments, and homologues thereof. Also provided is an antibody that specifically binds to the mTFP variant. The present invention further provides a tandem dimer comprising two mTFP dimers, operatively linked by a peptide linker.
    Type: Grant
    Filed: May 19, 2006
    Date of Patent: September 7, 2010
    Assignee: The Governors of the University of Alberta
    Inventors: Robert Earl Campbell, Hui-Wang Ai
  • Publication number: 20090170194
    Abstract: An isolated nucleic acid sequence encoding a non-oligomerizing Clavularia teal fluorescent protein (TFP) variant having a tyrosine-derived chromophore, and fragments and derivatives thereof. Also provided is a method for engineering the nucleic acid sequence, a vector comprising the nucleic acid sequence, a host cell comprising the vector, and use of the vector in a method for expressing the nucleic acid sequence. The present invention further provides an isolated nucleic acid, or mimetic or complement thereof, that hybridizes under stringent conditions to the nucleic acid sequence. Additionally, the present invention provides a non-oligomerizing TFP variant encoded by the nucleic acid sequence, as well as derivatives, fragments, and homologues thereof. Also provided is an antibody that specifically binds to the TFP variant. The present invention further provides a tandem dimer comprising two TFP dimers, operatively linked by a peptide linker.
    Type: Application
    Filed: November 30, 2007
    Publication date: July 2, 2009
    Applicant: THE GOVERNORS OF THE UNIVERSITY OF ALBERTA
    Inventors: Robert Earl CAMPBELL, Hui-Wang AI
  • Publication number: 20060275827
    Abstract: The present invention provides an isolated nucleic acid sequence encoding a non-oligomerizing Clavularia teal fluorescent protein (mTFP) variant having a tyrosine-derived chromophore, as well as fragments and derivatives thereof Also provided is a method for engineering the nucleic acid sequence, a vector comprising the nucleic acid sequence, a host cell comprising the vector, and use of the vector in a method for expressing the nucleic acid sequence. The present invention further provides an isolated nucleic acid, or mimetic or complement thereof, that hybridizes under stringent conditions to the nucleic acid sequence. Additionally, the present invention provides a non-oligomerizing mTFP variant encoded by the nucleic acid sequence, as well as derivatives, fragments, and homologues thereof. Also provided is an antibody that specifically binds to the mTFP variant. The present invention further provides a tandem dimer comprising two mTFP dimers, operatively linked by a peptide linker.
    Type: Application
    Filed: May 19, 2006
    Publication date: December 7, 2006
    Applicant: THE GOVERNORS OF THE UNIVERSITY OF ALBERTA
    Inventors: Robert Campbell, Hui-Wang Ai